Description:
AbbVie Inc is a leading American biopharmaceutical company, established in 2013 from a spin-off of Abbott Laboratories. The company specializes in the research, development, and commercialization of advanced therapies in immunology, oncology, virology, and neuroscience. With a robust pipeline of innovative treatments, AbbVie is committed to addressing some of the world's most challenging health issues and is recognized for its blockbuster immunology drug, Humira. AbbVie continues to strengthen its portfolio through strategic acquisitions and collaborations, positioning itself as a formidable player in the global biopharmaceutical landscape.
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, UNITED STATES, 60064-6400
Fiscal year end:
December
Market capitalization:
$413 Billion
Dividend per share:
$6.47
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
+547%
How much will you get:
$6,471
Prices dates:
30-09-2015: $35.78 and 30-09-2025: $231.54